Monolacunary polyoxotungstates [alpha(1)-P(2)W(17)O(61)](10-) and [alpha-PW(11)O(39)](7-) react with HfCl(4) to yield [alpha(1)-HfP(2)W(17)O(61)](6-) and [alpha-Hf(OH)PW(11)O(39)](4-), isolated as organo-soluble tetrabutylammonium (TBA) salts. Subsequent analyses, including mass spectrometry, show that they are stronger Lewis acids than (TBA)(5)H(2)[alpha(1)-YbP(2)W(17)O(61)]. The new polyoxotungstates catalyze Lewis acid mediated organic reactions, such as Mukaiyama aldol and Mannich-type additions. In particular, reactions with aldehydes, which were impossible with lanthanide polyoxotungstates, are made possible. Thus these modifications of the polyoxometalate composition allowed fine tuning of the Lewis acidity. The catalysts could be easily recovered and reused.
No takes yet. Share an insight, caveat, or question.
Boglio et al. (2007) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: